Postoperative Hypoparathyroidism: Prognosis, Prevention, and Treatment (Review)

This review summarizes the results of studies concerning the problem of post-surgical hypoparathyroidism, a common complication of thyroid gland surgery, decreasing the quality of life in patients and, in some cases, leading to disability.

A search for publications was carried out in electronic databases Web of Science, Scopus, Academic Search Complete (EBSCO), eLIBRARY, using keywords. The search depth was 7–10 years. Prevalence of post-surgical hypoparathyroidism was evaluated, the pathogenetic causes of the disease development, its clinical forms, methods of diagnosis and treatment were studied. It has been found that there is no single algorithm for analyzing the prognostic factors for the development of this pathological condition. It is emphasized that drug therapy of post-surgical hypoparathyroidism has a number of adverse effects. Therefore, the issues of prevention and surgical correction are of particular relevance. However, controversial opinions of contemporary authors about their clinical effectiveness determine the scientific and practical significance of further research on these issues.

1. Dedov I.I., Kuznetsov N.S., Mel’nichenko G.A. Endokrinnaya khirurgiya [Endocrine surgery]. Moscow: Literatura; 2011; 352 p.
2. Zarivchatskiy M.F., Bogatyrev O.P., Blinov S.A., Denisov S.A., Kolevatov A.P. Osnovy khirurgicheskoy endokrinologii [Fundamentals of surgical endocrinology]. Perm’; 2014; 369 p.
3. Chernikov R.A., Vorobjov S.L., Slepzov I.V., Semenov A.A., Chinchuk I.K., Makaryin V.A., Kulyash A.G., Uspenskaya A.A., Timofeyeva N.I., Novokshonov K.Yu., Karelina Yu.V., Fedorov E.A., Isheyskaya M.S., Fedotov Yu.N., Bubnov A.N. Nodular goiter (epidemiology and diagnostics). Klinicheskaya i eksperimental’naya tireoidologiya 2013; 9(2): 29–35.
4. Clarke B.L., Brown E.M., Collins M.T., Jüppner H., Lakatos P., Levine M.A., Mannstadt M.M., Bilezikian J.P., Romanischen A.F., Thakker R.V. Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab 2016; 101(6): 2284–2299, https://doi.org/10.1210/jc.2015-3908.
5. Kakava K., Tournis S., Papadakis G., Karelas I., Stampouloglou P., Kassi E., Triantafillopoulos I., Villiotou V., Karatzas T. Postsurgical hypoparathyroidism: a systematic review. In Vivo 2016; 30(3): 171–179.
6. Powers J., Joy K., Ruscio A., Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 2013; 28(12): 2570–2576, https://doi.org/10.1002/jbmr.2004.
7. Asari R., Passler C., Kaczirek K., Scheuba C., Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg 2008; 143(2): 132–138, https://doi.org/10.1001/archsurg.2007.55.
8. Khryshchanovich V.Ya., Tret’yak S.I. Problems of substitution therapy for postoperative hypothyroidism. Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta 2011; 1: 89–98.
9. Mokrysheva N.G., Eremkina A.K., Kovaleva E.V. Hypoparathyroidism: etiology, clinical manifestation, current diagnostics and treatment. Alʹmanah klinicheskoj mediciny 2016; 44(4): 477–492.
10. Agarwal P., Prakash M., Singhal M., Bhadada S.K., Gupta Y., Khandelwal N. To assess vascular calcification in the patients of hypoparathyroidism using multidetector computed tomography scan. Indian J Endocrinol Metab 2015; 19(6): 785–790, https://doi.org/10.4103/2230-8210.167545.
11. Edafe O., Antakia R., Laskar N., Uttley L., Balasubramanian S.P. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg 2014; 101(7): 883–884, https://doi.org/10.1002/bjs.9538.
12. Cho N.L., Moalem J., Chen L., Lubitz C.C., Moore F.D. Jr., Ruan D.T. Surgeons and patients disagree on the potential consequences from hypoparathyroidism. Endocr Pract 2014; 20(5): 427–446, https://doi.org/10.4158/ep13321.or.
13. Chapman D.B., French C.C., Leng X., Browne J.D., Waltonen J.D., Sullivan C.A. Parathyroid hormone early percent change: an individualized approach to predict postthyroidectomy hypocalcemia. Am J Otolaryngol 2012; 33(2): 216–220, https://doi.org/10.1016/j.amjoto.2011.06.004.
14. Dora S.V., Gudieva M.B., Volkova A.R., Peikrishvili N.E., Shilova E.S. Postoperative hypocalcemia in patients operated on the Graves’ disease. Vestnik Rossijskoj voenno-medicinskoj akademii 2015; 52(4): 109–112.
15. Pesce C.E., Shiue Z., Tsai H.L., Umbricht C.B., Tufano R.P., Dackiw A.P., Kowalski J., Zeiger M.A. Postoperative hypocalcemia after thyroidectomy for Graves’ disease. Thyroid 2010; 20(11): 1279–1283, https://doi.org/10.1089/thy.2010.0047.
16. Bilezikian J.P., Khan A., Potts J.T. Jr., Brandi M.L., Clarke B.L., Shoback D., Jüppner H., D’Amour P., Fox J., Rejnmark L., Mosekilde L., Rubin M.R., Dempster D., Gafni R., Collins M.T., Sliney J., Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011; 26(10): 2317–2337, https://doi.org/10.1002/jbmr.483.
17. Savenok E.V. Conservative treatment hypoparatireosae after extrafascial operations on the thyroid gland. Sistemnyj analiz i upravlenie v biomedicinskih sistemah 2011; 10(4): 900–903.
18. Iglesias P., Díez J.J. Endocrine complications of surgical treatment of thyroid cancer: an update. Exp Clin Endocrinol Diabetes 2017; 125(8): 497–505, https://doi.org/10.1055/s-0043-106441.
19. Lorente-Poch L., Sancho J.J., Muñoz-Nova J.L., Sánchez-Velázquez P., Sitges-Serra A. Defining the syndromes of parathyroid failure after total thyroidectomy. Gland Surg 2015; 4(1): 82–90, https://doi.org/10.3978/j.issn.2227-684X.2014.12.04.
20. Kamath S.D., Rao B.S. Delayed post-surgical hypoparathyroidism: the forgotten chameleon! J Clin Diagn Res 2017; 11(2): OD07–OD09, https://doi.org/10.7860/jcdr/2017/23609.9260.
21. McCullough M., Weber C., Leong C., Sharma J. Safety, efficacy, and cost savings of single parathyroid hormone measurement for risk stratification after total thyroidectomy. Am Surg 2013; 79(8): 768–774.
22. Ritter K., Elfenbein D., Schneider D.F., Chen H., Sippel R.S. Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res 2015; 197(2): 348–353, https://doi.org/10.1016/j.jss.2015.04.059.
23. Shoback D.M., Bilezikian J.P., Costa A.G., Dempster D., Dralle H., Khan A.A., Peacock M., Raffaelli M., Silva B.C., Thakker R.V., Vokes T., Bouillon R. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab 2016; 101(6): 2300–2312, https://doi.org/10.1210/jc.2015-3909.
24. Shulutko A.M., Semikov V.I., Gryaznov S.E., Gorbacheva A.V., Patalova A.R., Mansurova G.T., Kazakova V.A. Risk of hypocalcemia after thyroid surgery. Khirurgiya. Zhurnal im. N.I. Pirogova 2015; 11: 35–40.
25. Nair C.G., Babu M.J., Menon R., Jacob P. Hypocalcaemia following total thyroidectomy: an analysis of 806 patients. Indian J Endocrinol Metab 2013; 17(2): 298–303, https://doi.org/10.4103/2230-8210.109718.
26. Lorente-Poch L., Sancho J.J., Ruiz S., Sitges-Serra A. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg 2015; 102(4): 359–367, https://doi.org/10.1002/bjs.9676.
27. Erbil Y., Ozbey N.C., Sari S., Unalp H.R., Agcaoglu O., Ersоz F., Issever H., Ozarmagan S. Determinants of postoperative hypocalcemia in vitamin D-deficient Graves’ patients after total thyroidectomy. Am J Surg 2011; 201(5): 685–691, https://doi.org/10.1016/j.amjsurg.2010.04.030.
28. Sanabria A., Dominguez L.C., Vega V., Osorio C., Duarte D. Routine postoperative administration of vitamin D and calcium after total thyroidectomy: a meta-analysis. Int J Surg 2011; 9(1): 46–51, https://doi.org/10.1016/j.ijsu.2010.08.006.
29. Kirkby-Bott J., Markogiannakis H., Skandarajah A., Cowan M., Fleming B., Palazzo F. Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg 2011; 35(2): 324–330, https://doi.org/10.1007/s00268-010-0872-y.
30. Pradeep P.V., Ramalingam K. Postoperative PTH measurement is not a reliable predictor for hypocalcemia after total thyroidectomy in vitamin D deficiency: prospective study of 203 cases. World J Surg 2014; 38(3): 564–567, https://doi.org/10.1007/s00268-013-2350-9.
31. Kuznetsov N.S., Simakina O.V., Kim I.V. Predictors of postoperative hypoparathyroidism after thyroidectomy and methods of treatment. Klinicheskaya i eksperimental’naya tireoidologiya 2012; 8(2): 20–30.
32. Simakina O.V., Latkina N.V., Kuznetsov N.S. Comparative evaluation of preand postoperative predictors of hypocalcemia in patients with thyroid cancer. Endokrinnaya hirurgia 2014; 8(3): 14–22.
33. Mannstadt M., Bilezikian J.P., Thakker R.V., Hannan F.M., Clarke B.L., Rejnmark L., Mitchell D.M., Vokes T.J., Winer K.K., Shoback D.M. Hypoparathyroidism. Nat Rev Dis Primers 2017; 3: 17055, https://doi.org/10.1038/nrdp.2017.55.
34. Potemkin V.V. Endokrinologiya [Endocrinology]. Moscow: Meditsinskoe informatsionnoe agentstvo; 2013; 776 p.
35. Kuznetsov N.S., Latkina N.V., Simakina O.V. Hypoparathyroidism. Endokrinnaya hirurgia 2012; 6(3): 47–53.
36. Khan M.I., Waguespack S.G., Hu M. Medical management of postsurgical hypoparathyroidism. Endocr Pract 2011; 17(Suppl 1): 18–25, https://doi.org/10.4158/ep10302.ra.
37. Fong J., Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician 2012; 58(2): 158–162.
38. Edafe O., Balasubramanian S.P. Incidence, prevalence and risk factors for post-surgical hypocalcaemia and hypoparathyroidism. Gland Surg 2017; 6(Suppl 1): S59–S68, https://doi.org/10.21037/gs.2017.09.03.
39. Underbjerg L., Sikjaer T., Mosekilde L., Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 2013; 28(11): 2277–2285, https://doi.org/10.1002/jbmr.1979.
40. Ballane G.T., Sfeir J.G., Dakik H.A., Brown E.M., El-Hajj Fuleihan G. Use of recombinant human parathyroid hormone in hypocalcemic cardiomyopathy. Eur J Endocrinol 2012; 166(6): 1113–1120, https://doi.org/10.1530/eje-11-1094.
41. Rentoukas E., Lazaros G., Sotiriou S., Athanassiou M., Tsiachris D., Deftereos S., Stefanadis C. Extreme but not life-threatening QT interval prolongation? Take a closer look at the neck! J Electrocardiol 2013; 46(2): 128–130, https://doi.org/10.1016/j.jelectrocard.2012.10.007.
42. Kim J.H., Chung M.K., Son Y.I. Reliable early prediction for different types of post-thyroidectomy hypocalcemia. Clin Exp Otorhinolaryngol 2011; 4(2): 95–100, https://doi.org/10.3342/ceo.2011.4.2.95.
43. Promberger R., Ott J., Kober F., Karik M., Freissmuth M., Hermann M. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy. Thyroid 2011; 21(2): 145–150, https://doi.org/10.1089/thy.2010.0067.
44. Sands N., Young J., MacNamara E., Black M.J., Tamilia M., Hier M.P., Payne R.J. Preoperative parathyroid hormone levels as a predictor of postthyroidectomy hypocalcemia. Otolaryngol Head Neck Surg 2011; 144(4): 518–521, https://doi.org/10.1177/0194599810395114.
45. Lazard D.S., Godiris-Petit G., Wagner I., Sarfati E., Chabolle F. Early detection of hypocalcemia after total/completion thyroidectomy: routinely usable algorithm based on serum calcium level. World J Surg 2012; 36(11): 2590–2597, https://doi.org/10.1007/s00268-012-1727-5.
46. Komissarenko Yu.I., Bobryk M.I., Sidorova I.V., Burka O.A. Current European guidelines on the management of chronic hypoparathyroidism in adults according to the materials of the 17th Congress of the European Society of Endocrinology, Dublin, Ireland, 16–20 May 2015. Mizhnarodnij endokrinologichnij zhurnal 2015; 69(5): 59–64.
47. Bollerslev J., Rejnmark L., Marcocci C., Shoback D.M., Sitges-Serra A., van Biesen W., Dekkers O.M.; European Society of Endocrinology. European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 2015; 173(2): G1–G20, https://doi.org/10.1530/eje-15-0628.
48. Bolland M.J., Grey A., Avenell A., Gamble G.D., Reid I.R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040, https://doi.org/10.1136/bmj.d2040.
49. Chia S.H., Weisman R.A., Tieu D., Kelly C., Dillmann W.H., Orloff L.A. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery. Arch Otolaryngol Head Neck Surg 2006; 132(1): 41–45.
50. Press D., Politz D., Lopez J., Norman J. The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism. Surgery 2011; 150(6): 1061–1068, https://doi.org/10.1016/j.surg.2011.09.018.
51. Graff A.T., Miller F.R., Roehm C.E., Prihoda T.J. Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels. Ear Nose Throat J 2010; 89(9): 462–465.
52. Kovacevic B., Ignjatovic M., Cuk V., Zivaljevic V., Paunović I. Early prediction of symptomatic hypocalcemia after total thyroidectomy. Acta Chir Belg 2011; 111(5): 303–307.
53. Wang T.S., Roman S.A., Sosa J.A. Postoperative calcium supplementation in patients undergoing thyroidectomy. Curr Opin Oncol 2012; 24(1): 22–28, https://doi.org/10.1097/cco.0b013e32834c4980.
54. Chindavijak S. Prediction of hypocalcemia in postoperative total thyroidectomy using single measurement of intra-operative parathyroid hormone level. J Med Assoc Thai 2007; 90(6): 1167–1171.
55. Proczko-Markuszewska M., Kobiela J., Stefaniak T., Lachiński A.J., Sledziński Z. Postoperative PTH measurement as a predictor of hypocalcaemia after thyroidectomy. Acta Chir Belg 2010; 110(1): 40–44, https://doi.org/10.1080/00015458.2010.11680563.
56. Simakina O.V., Latkina N.V., Kim I.V., Kuznetsov N.S. The prognostic value of parathyroid hormone for the diagnosis of early postoperative hypocalcemia after thyroidectomy. Endokrinnaya hirurgia 2014; 2: 4–8.
57. Sam A.H., Dhillo W.S., Donaldson M., Meeran K., Tolley N.S., Palazzo F.F. Serum parathyroid hormone is not an accurate predictor of postthyroidectomy hypocalcemia in vitamin D-deficient patients: a pilot study. Clin Chem 2011; 57(8): 1206–1207, https://doi.org/10.1373/clinchem.2011.162909.
58. Grebennikova T.A., Belaya Zh.E., Melnichenko G.A. Hypoparathyroidism: disease update and new methods of treatment. Endokrinnaya hirurgia 2017; 11(2): 70–80.
59. Bilezikian J.P., Brandi M.L., Cusano N.E., Mannstadt M., Rejnmark L., Rizzoli R., Rubin M.R., Winer K.K., Liberman U.A., Potts J.T. Jr. Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 2016; 101(6): 2313–2324, https://doi.org/10.1210/jc.2015-3910.
60. Clarke B.L. Epidemiology and complications of hypoparathyroidism. Endocrinol Metab Clin North Am 2018; 47(4): 771–782, https://doi.org/10.1016/j.ecl.2018.07.004.
61. Luk’yanchikov V.S. Hypocalcemia. Russkij medicinskij zurnal 2013; 28: 1429–1431.
62. Farkhutdinova L.M., Ivanova M.A., Tunik V.F. Hypoparathyroidism: modern concepts and analysis of a clinical case. Arhiv vnutrennej mediciny 2016; 6(3): 71–76.
63. Mitchell D.M., Regan S., Cooley M.R., Lauter K.B., Vrla M.C., Becker C.B., Burnett-Bowie S.A., Mannstadt M. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 2012; 97(12): 4507–4514, https://doi.org/10.1210/jc.2012-1808.
64. Guarnotta V., Riela S., Massaro M., Bonventre S., Inviati A., Ciresi A., Pizzolanti G., Benvenga S., Giordano C. The daily consumption of cola can determine hypocalcemia: a case report of postsurgical hypoparathyroidism-related hypocalcemia refractory to supplemental therapy with high doses of oral calcium. Front Endocrinol (Lausanne) 2017; 8: 7, https://doi.org/10.3389/fendo.2017.00007.
65. Balasubramanian S.P. Iatrogenic/post-surgical hypoparathyroidism: where do we go from here? Endocrine 2014; 47(2): 357–359, https://doi.org/10.1007/s12020-014-0397-5.
66. Stack B.C. Jr., Bimston D.N., Bodenner D.L., Brett E.M., Dralle H., Orloff L.A., Pallota J., Snyder S.K., Wong R.J., Randolph G.W. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: postoperative hypoparathyroidism — definitions and management. Endocr Pract 2015; 21(6): 674–685, https://doi.org/10.4158/ep14462.dsc.
67. Abate E.G., Clarke B.L. Review of hypoparathyroidism. Front Endocrinol (Lausanne) 2017; 7: 172, https://doi.org/10.3389/fendo.2016.00172.
68. Wang H., Liu J., Yin Y., Wu J., Wang Z., Miao D., Sun W. Recombinant human parathyroid hormone related protein 1-34 and 1-84 and their roles in osteoporosis treatment. PLoS One 2014; 9(2): e88237, https://doi.org/10.1371/journal.pone.0088237.
69. Mannstadt М., Clarke B.L., Vokes T., Brandi M.L., Ranganath L., Fraser W.D., Lakatos P., Bajnok L., Garceau R., Mosekilde L., Lagast H., Shoback D., Bilezikian J.P. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 2013; 1(4): 275–283, https://doi.org/10.1016/s2213-8587(13)70106-2.
70. Cusano N.E., Rubin M.R., Bilezikian J.P. Parathyroid hormone therapy for hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2015; 29(1): 47–55, https://doi.org/10.1016/j.beem.2014.09.001.
71. Brandi M.L., Bilezikian J.P., Shoback D., Bouillon R., Clarke B.L., Thakker R.V., Khan A.A., Potts J.T. Jr. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 2016; 101(6): 2273–2283, https://doi.org/10.1210/jc.2015-3907.
72. Sikjaer T., Rolighed L., Hess A., Fuglsang-Frederiksen A., Mosekilde L., Rejnmark L. Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int 2014; 25(6): 1717–1726, https://doi.org/10.1007/s00198-014-2677-6.
73. Kuriloff D.B., Sanborn K.V. Rapid intraoperative localization of parathyroid glands utilizing methylene blue infusion. Otolaryngol Head Neck Surg 2004; 131(5): 616–622, https://doi.org/10.1016/j.otohns.2004.04.026.
74. Kirpa E.A., Reshetov I.V., Golubtsov A.K., Slavnova E.N. Methods for visualization of parathyroid gland. Onkohirurgiya 2013; 5(1): 66–72.
75. Akasu H., Igarashi T., Tanaka K., Shimizu K. Photodynamic identification of human parathyroid glands with 5-aminolevulinic acid. J Nippon Med Sch 2006; 73(5): 246–247, https://doi.org/10.1272/jnms.73.246.
76. Sleptsov I.V., Chernikov R.A., Bubnov A.N., Fedotov Yu.N., Semenov A.A., Chinchuk I.K., Makar’in V.A., Uspenskaya A.A., Karelina Yu.V. Photodynamic imaging of the parathyroid glands during thyroid surgery. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo medicinskogo universiteta im. akad. I.P. Pavlova 2012; 19(1): 124–125.
77. Kirpa E.A., Reshetov I.V., Filonenko E.V., Golubtsov A.K. Intraoperative identification of the parathyroid glands in the treatment of thyroid cancer. Onkokhirurgiya 2011; 3(2): 39–40.
78. Elbassiouny S., Fadel M., Elwakil T., Elbasiouny M.S. Photodynamic diagnosis of parathyroid glands with nano-stealth aminolevulinic acid liposomes. Photodiagnosis Photodyn Ther 2018; 21: 71–78, https://doi.org/10.1016/j.pdpdt.2017.11.004.
79. McWade M.A., Paras C., White L.M., Phay J.E., Mahadevan-Jansen A., Broome J.T. A novel optical approach to intraoperative detection of parathyroid glands. Surgery 2013; 154(6): 1371–1377, https://doi.org/10.1016/j.surg.2013.06.046.
80. Suh Y.J., Choi J.Y., Chai Y.J., Kwon H., Woo J.W., Kim S.J., Kim K.H., Lee K.E., Lim Y.T., Youn Y.K. Indocyanine green as a near-infrared fluorescent agent for identifying parathyroid glands during thyroid surgery in dogs. Surg Endosc 2015; 29(9): 2811–2817, https://doi.org/10.1007/s00464-014-3971-2.
81. Gao B., Tian W., Jiang Y., Zhang S., Guo L., Zhao J., Zhang G., Hao S., Xu Y., Luo D. Application of carbon nanoparticles for parathyroid protection in reoperation of thyroid diseases. Int J Clin Exp Med 2015; 8(12): 22254–22261.
82. Gu J., Wang J., Nie X., Wang W., Shang J. Potential role for carbon nanoparticles identification and preservation in situ of parathyroid glands during total thyroidectomy and central compartment node dissection. Int J Clin Exp Med 2015; 8(6): 9640–9648.
83. Veyseller B., Aksoy F., Yildirim Y.S., Karatas A., Ozturan O. Effect of recurrent laryngeal nerve identification technique in thyroidectomy on recurrent laryngeal nerve paralysis and hypoparathyroidism. Arch Otolaryngol Head Neck Surg 2011; 137(9): 897–900, https://doi.org/10.1001/archoto.2011.134.
84. Mumladze R.B., Dolidze D.D., Vasil’ev I.T., Markov I.N., Yakushin V.I., Vardanyan A.V., Tsarev M.I., Nuzhdin O.I., Sultygov A.Kh., Dzhigkaev T.D., Siukaev O.N., Shie M., Olimpiev M.Yu. Features of the prevention of specific complications in the surgical treatment of patients with thyroid diseases. Moskovskij hirurgicheskij zhurnal 2013; 31(3): 4–11.
85. Duboshina T.B., Askerov M.R., Romanovskaya I.A. The mode of prevention of specific complications under operations of thyroid. Lechenie i profilaktika 2016; 18(2): 94–97.
86. Slavin L.E., Chugunov A.N., Khasanshin M.M. The experience of access application to recurrent laryngeal nerve and parathyroid glands as the way of the postoperative complications prevention in case of video-assisted surgery. Kazanskij medicinskij zhurnal 2014; 95(2): 282–284.
87. Duke W.S., White J.R., Waller J.L., Terris D.J. Six-year experience with endoscopic thyroidectomy: outcomes and safety profile. Ann Otol Rhinol Laryngol 2015; 124(11): 915–920, https://doi.org/10.1177/0003489415591837.
88. Zhang P., Zhang H.W., Han X.D., Di J.Z., Zheng Q. Meta-analysis of comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy. Eur Rev Med Pharmacol Sci 2015; 19(8): 1381–1387.
89. Del Rio P., Viani L., Montana C.M., Cozzani F., Sianesi M. Minimally invasive thyroidectomy: a ten years experience. Gland Surg 2016; 5(3): 295–299, https://doi.org/10.21037/gs.2016.01.04.
90. Bellotti C., Capponi M.G., Cinquepalmi M., Castagnola G., Marchetta S., Mallozzi F., Pezzatini M., Brescia A. MIVAT: the last 2 years experience, tips and techniques after more than 10 years. Surg Endosc 2018; 32(5): 2340–2344, https://doi.org/10.1007/s00464-017-5929-7.
91. Ayusheeva A.V., Iljicheva E.A., Lepekhova S.A. Postoperative hypoparathyreosis, ways of prevention and correction. Byulleten’ VSNTs SO RAMN 2013; (89)1: 160–164.
92. Moffett J.M., Suliburk J. Parathyroid autotransplantation. Endocr Pract 2011; 17(Suppl 1): 83–89, https://doi.org/10.4158/ep10377.ra.
93. Toneto M.G., Prill S., Debon L.M., Furlan F.Z., Steffen N. The history of the parathyroid surgery. Rev Col Bras Cir 2016; 43(3): 214–222, https://doi.org/10.1590/0100-69912016003003.
94. Famà F., Cicciù M., Polito F., Cascio A., Gioffré-Florio M., Piquard A., Saint-Marc O., Sindoni A. Parathyroid autotransplantation during thyroid surgery: a novel technique using a cell culture nutrient solution. World J Surg 2017; 41(2): 457–463, https://doi.org/10.1007/s00268-016-3754-0.
95. Cheren’ko S.M., Larіn O.S., Sіchinava R.M., Khoperіya V.G., Cherpak B.D. Postoperative hypoparathyroidism prevention in thyroid surgery using a new method of parathyroid autotransplantation. Klinìchna endokrinologia ta endokrinna hirurgia 2014; 48(3): 3–8.
96. Ahmed N., Aurangzeb M., Muslim M., Zarin M. Routine parathyroid autotransplantation during total thyroidectomy: a procedure with predictable outcome. J Pak Med Assoc 2013; 63(2): 190–193.
97. Krausz M.M., Ashkenazi I., Alfici R. Parathyroid autotransplantaion in adults and children. Harefuah 2017; 156(3): 167–170.
98. Erikoglu M., Colak B., Toy H., Gurbilek M. Parathyroid autotransplantation in rats having hypoparathyroidism. Int J Clin Exp Med 2015; 8(9): 16328–16333.
99. Popov O.S., Logvinov S.V., Lyan N.I., Larionov M.M., Galyan A.N., Gasparyan S.N., Geydarov R.Ya., Galyan Ye.V., Baikov A.N., Udut V.V. Parathyroid glands autotransplantation in the postoperative hypoparathyroidism prevention. Bulletenʹ sibirskoj mediciny 2011; 10(3): 125–128.
100. Tartaglia F., Blasi S., Giuliani А., Merola R., Livadoti G., Krizzuk D., Tortorelli G., Tromba L. Parathyroid autotransplantation during total thyroidectomy. Results of a retrospective study. Int J Surg 2016; 28(Suppl 1): S79–S83, https://doi.org/10.1016/j.ijsu.2015.05.059.
101. Lorente-Poch L., Sancho J., Muñoz J.L., Gallego-Otaegui L., Martínez-Ruiz C., Sitges-Serra A. Failure of fragmented parathyroid gland autotransplantation to prevent permanent hypoparathyroidism after total thyroidectomy. Langenbecks Arch Surg 2017; 402(2): 281–287, https://doi.org/10.1007/s00423-016-1548-3.
102. Sitges-Serra A., Lorente-Poch L., Sancho J. Parathyroid autotransplantation in thyroid surgery. Langenbecks Arch Surg 2018; 403(3): 309–315, https://doi.org/10.1007/s00423-018-1654-5.
103. Liu H.G., Chen Z.C., Zhang X.H., Yang K. Replantation with cryopreserved parathyroid for permanent hypoparathyroidism: a case report and review of literatures. Int J Clin Exp Med 2015; 8(3): 4611–4619.
104. Khryshchanovich V., Ghoussein Y. Allotransplantation of macroencapsulated parathyroid cells as a treatment of severe postsurgical hypoparathyroidism: case report. Ann Saudi Med 2016; 36(2): 143–147, https://doi.org/10.5144/0256-4947.2016.21.3.1130.
105. Iovino F., Armano G., Auriemma P.P., Sergio R., De Sena G., Capuozzo V., Rosso F., Marino G., Papale F., Grimaldi A., Barbarisi A. L’ingegnerizzazione tissutale delle cellule paratiroidee. G Chir 2010; 31(6–7): 312–315.

Melikyan A.A., Menkov A.V. Postoperative Hypoparathyroidism: Prognosis, Prevention, and Treatment (Review). Sovremennye tehnologii v medicine 2020; 12(2): 101, https://doi.org/10.17691/stm2020.12.2.13